ESSA Pharma Inc. (EPIX)

NASDAQ: EPIX · IEX Real-Time Price · USD
2.98
+0.09 (3.11%)
Aug 12, 2022 4:30 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Year 20212020201920182017201620152014
Selling, General & Admin
12.8811.375.465.935.145.645.261.07
Research & Development
24.2612.156.74.875.7313.064.980.67
Operating Expenses
37.1423.5212.1510.810.8718.710.231.74
Operating Income
-37.14-23.52-12.15-10.8-10.87-18.7-10.23-1.74
Interest Expense / Income
0.020.620.60.910.780.940.090.09
Other Expense / Income
-0.33-0.4-0.04-0.11-7.27-6.65-0.65-0
Pretax Income
-36.84-23.73-12.72-11.6-4.38-12.99-9.68-1.82
Income Tax
-0.03-0.290.040.030.120.1500
Net Income
-36.81-23.45-12.76-11.63-4.5-13.14-9.68-1.82
Net Income Common
-36.81-23.45-12.76-11.63-4.5-13.14-9.68-1.82
Shares Outstanding (Basic)
3822851111
Shares Outstanding (Diluted)
3822851111
Shares Change
71.45%166.13%84.68%213.86%8.16%46.59%16.99%-
EPS (Basic)
-0.96-1.04-1.51-2.55-3.09-9.77-10.60-2.40
EPS (Diluted)
-0.96-1.04-1.51-2.55-3.09-9.77-10.60-2.40
Free Cash Flow Per Share
-0.66-0.76-1.45-2.24-11.93-11.38-14.73-2.65
Effective Tax Rate
0.09%1.22%-0.30%-0.23%-2.66%-1.16%0.00%0.00%
EBITDA
-36.71-23.01-12.12-10.66-3.55-11.98-9.54-1.71
Depreciation & Amortization
0.110.1100.030.050.070.040.02
EBIT
-36.82-23.12-12.12-10.69-3.6-12.05-9.58-1.74
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).